dc.contributor.author | Christensen, Ingrid Egeland | |
dc.contributor.author | Jyssum, Ingrid | |
dc.contributor.author | Tveter, Anne Therese | |
dc.contributor.author | Sexton, Joseph | |
dc.contributor.author | Tran, Trung | |
dc.contributor.author | Mjaaland, Siri | |
dc.contributor.author | Kro, Grete Anette Birkeland | |
dc.contributor.author | Kvien, Tore Kristian | |
dc.contributor.author | Warren, David | |
dc.contributor.author | Jahnsen, Jørgen | |
dc.contributor.author | Munthe, Ludvig Andre | |
dc.contributor.author | Haavardsholm, Espen A. | |
dc.contributor.author | Vaage, John T. | |
dc.contributor.author | Grødeland, Gunnveig | |
dc.contributor.author | Lund-Johansen, Fridtjof | |
dc.contributor.author | Jørgensen, Kristin Kaasen | |
dc.contributor.author | Syversen, Silje Watterdal | |
dc.contributor.author | Goll, Guro Løvik | |
dc.contributor.author | Provan, Sella Aarrestad | |
dc.date.accessioned | 2022-11-28T11:50:47Z | |
dc.date.available | 2022-11-28T11:50:47Z | |
dc.date.created | 2022-11-16T15:13:48Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | BMC Medicine. 2022, 20 (1), 1-13. | en_US |
dc.identifier.issn | 1741-7015 | |
dc.identifier.uri | https://hdl.handle.net/11250/3034461 | |
dc.description.abstract | The durability of vaccine-induced humoral immunity against SARS-CoV-2 in patients with immune mediated inflammatory diseases (IMIDs) on immunosuppressive therapy is not known. The aim of this study was to compare the persistence of anti-Spike antibodies following two-dose SARS-CoV-2 vaccination between IMID patients and healthy controls and to identify factors associated with antibody decline. | en_US |
dc.language.iso | eng | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.subject | SARS-CoV-2 vaccine | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Serologic response | en_US |
dc.subject | Rheumatic diseases | en_US |
dc.subject | Infammatory bowel disease | en_US |
dc.title | The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study | en_US |
dc.title.alternative | The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.subject.nsi | VDP::Matematikk og Naturvitenskap: 400 | en_US |
dc.source.pagenumber | 1-13 | en_US |
dc.source.volume | 20 | en_US |
dc.source.journal | BMC Medicine | en_US |
dc.source.issue | 1 | en_US |
dc.identifier.doi | 10.1186/s12916-022-02587-8 | |
dc.identifier.cristin | 2075057 | |
dc.relation.project | Norges forskningsråd: 328657 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |